Background Lung cancer is the leading cause of cancer deaths worldwide. Clinical staging
of lung cancer plays a crucial role in making treatment decisions and evaluating prognosis. …

… I, II, III, or IV) was the outcome, and we included the introduction of low dose computed
tomography lung cancer screening in the US as a time varying covariate. We adjusted for sex, age…

… computed tomography (m-CT) value to predict tumor invasiveness and recurrence, and
further, to compare with other measurements such as consolidation/tumor ratio and solid tumor …

… of patients with nonsmall cell lung cancer, especially for … are used to stage patients with
non-small cell lung cancer. In … /CT in the TNM staging of the non-small cell lung cancer. Methods: …

… tomography-computed tomography (PET-CT); role of PET-CT has widened exponentially in
the management of lung cancer… of non small cell lung cancer with emphasis on staging of the …

… for non-small cell lung cancer (NSCLC) patients. However, conventional computed tomography
(CT) related prognostic factors may not apply to the challenging stage III NSCLC group. …

… data from three major lung cancer referral centres in Brisbane … stage extra-cranial disease.
BMS was defined as dedicated brain imaging with contrast-enhanced computed tomography (…

… this reason, we decided to compare long-term survival of lung cancer patients who do or
do not undergo MLNR in a large prospective cohort undergoing CT screening for lung cancer. …

… Following diagnosis of lung cancer, accurate staging is … tomography (PET) in conjunction
with computed tomography (… the multi-disciplinary management of lung cancer. This article will …

… Computed tomography (CT) examinations are increasingly used worldwide and incidental
… Lung cancer stage at diagnosis is pivotal to survival. The earliest stage of lung cancer, stage …